Pharmarise Holdings (2796) · InitiativeAchieved
Appointment of 2 Directors Nominated by a Capital and Business Alliance Partner
First written in FY2019-Q2. 1 of 2 entries say "Achieved", first in FY2020. Latest entry: FY2020.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Shareholder Governance Agreement with a Capital and Business Alliance PartnerA theme 15 companies write about · 1 as a headwind · 10 as a tailwind
0 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.Full recordFilings, disclosures and news, newest first
- FY2020AchievedAnnual report
「The appointment of the individual was based on the capital and business alliance agreement announced on 8 November 2018 between the company, Aspirant Group Co., Ltd. and AG2 Investment Limited Partnership, which Aspirant Group operates and manages, under which 2 individuals from Aspirant Group would participate in the company's management as directors.」
The acceptance of 2 directors under the capital and business alliance agreement was implemented through the appointment of Hara Tomomi (原知己) and Nakanishi Masaya (中西雅也). - FY2019-Q2First statedAnnual report
「The company, AG and AG2 Fund agreed in the capital and business alliance agreement that AG or AG2 Fund could nominate 2 directors of the company.」
Under the capital and business alliance agreement, the parties agreed that AG or AG2 Fund could nominate 2 directors. The company planned to submit a proposal for the election of officers, including the 2 nominees, at the annual general meeting of shareholders scheduled for August 2019.